Stock page
Emergent Health Corp (EMGE)
Emergent Health Corp develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim a nutrient that enhances the immune system, nourishes stem cells and maintains health; Neuvitale which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest a diet aid that controls appetite in the brain and stomach; and EmergentO2, a water oxygenator, which increases oxygen in the bloodstream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, online, and various other retail outlets throughout the United States and internationally.
Quote snapshot
$0.0001
Daily change: —
ExchangeOTCPK
Updated2026-05-09T03:49:09.141304Z
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|